Table 2.
Positive rate and concordance rate of CD44/CD24 phenotypes in TNBC specimens with and without lymph node metastases
| Phenotype | Positive rate (%) | Concordance rate between patients with and without lymph node metastasis (%)* | |
|---|---|---|---|
|
| |||
| No. lymph node metastasis | Lymph node metastasis | ||
| CD44+CD24-/low | 51.7 (15/29) | 69 (20/29) | 51.7 (15/29) |
| CD44-CD24- | 48.3 (14/29) | 24.1 (7/29) | 24.1 (7/29) |
| CD44-CD24+ | 0 (0/29) | 6.9 (2/29) | 0 (0/29) |
| CD44+CD24+ | 0 (0/29) | 0 (0/29) | 0 (0/29) |
*
Concordance rate is calculated as a combination of both positive and negative cases in primary and lymph node metastasis, divided by total number of cases.